Please login to the form below

I have forgotten my password

Death leads to recall of batch of Takeda's Rienso in Switzerland

Switzerland flag

Marketing partner Amag also reports three other hypersensitivity reactions

Astellas gets first OK for prostate drug Vesomni

Approved in the Netherlands to treat men with lower urinary tract symptoms

Merck & Co inches closer to US green light for insomnia drug

FDA panel backs suvorexant, although some concerns about high dosages

GSK awarded $200m by US government for antibiotic research

Follows state-supported schemes in Europe to combat resistance to antibiotics

David Nicholson to step down as head of England’s NHS

Decision to retire comes two months after publication of Francis report into hospital scandal

Roche repeats cancer drugs warning as Avastin faces another NICE rejection

Concerns about future of Cancer Drugs Fund

Italian pharma market set for continued downturn

Will fall $1.6bn in value by 2020, says analyst GlobalData

Novartis wins third NICE recommendation for Lucentis

Gains final backing to treat NHS patients with macular oedema

France ignores EMA and suspends Bayer's Diane 35

National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict

Informational source shift: from marketing to medical

The changing role of medical information in HCP communications pathways

Chasing the cure for Parkinson's disease

Research for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
From paralysis to analysis: the journey to multichannel marketing

To make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier

ClinTec International expands into Turkey

CRO says new office will bolster its presence in the Middle East and North Africa
Royalty Pharma raises Elan bid as deals keep coming

Values Elan at about $6.5bn
Pfizer pulls late-stage trial of cancer drug in NHL

Inotuzumab ozogamicin fails to show survival benefit in phase III
Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn
Healthcare at Home and QED partner on orphan diseases

OrphanReach alliance will see companies provide product lifecycle services
New vortioxetine studies reinforce efficacy in depression

Supports marketing applications from Takeda and Lundbeck
India puts cost controls on medicines

Drugs (Prices Control) Order 2013 reduces price of hundreds of drugs

Latest appointments

Travyn Rhall takes global CEO role at Millward Brown

Rhall moves into role following successful seven-year stint as CEO, AMP
Edelman appoints Red Health's Paul Gittins

Founding member of Red Health to move to Edelman as managing director
Clare Gerada to step down as UK RCGP chair

Maureen Baker nominated as chair-elect
Health editor at The Sun newspaper joins Ruder Finn

Emma Morton appointed media strategist at PR firm
Boehringer's Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directors

More appointments

Featured jobs

Senior Brand Manager - Harlow: Competitive
Sales Manager - Media Publishing – Cheshire: 25,000 to 35,000 per annum
UK Marketing Director: 80,000 to 100,000 per annum
Group Account Director –Healthcare Advertising: Neg

Subscribe to our email news alerts

PMHub

Add my company

firstlight

Having a good story just isn’t good enough in today’s communications landscape. The audiences we need to reach ...

Latest intelligence

Clinical trial regulation in Mexico: Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing...
How can pharma deliver returns on increased digital investment?: Independent online professional networks work best as part of a multi-channel campaign ...
The impact of Hollande's healthcare reforms in France: A tougher environment for pharma, with market access and regulatory challenges...

Quick links

Multimedia

<>